[1]JournalofCardiovascularPharmacology,2000,vol.35,p.179-188
[2]Patent:US6482828,2002,B1
[3]EuropeanJournalofMedicinalChemistry,2016,vol.112,p.20-32
[1]JournalofCardiovascularPharmacology,2000,vol.35,p.179-188
[1]JournalofCardiovascularPharmacology,2000,vol.35,p.179-188
[1]JournalofCardiovascularPharmacology,2000,vol.35,p.179-188
[1]JournalofCardiovascularPharmacology,2000,vol.35,p.179-188
Title: Sudbeck EA, et al. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res. 1999 Jun;5(6):1569-82.
Title: Oh YB, et al. Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice. Exp Mol Med. 2013 May 17;45:e23
Title: Uckun FM, et al. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 -(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazoline. Clin Cancer Res. 1999 Oct;5(10):2954-62.
Title: Xia F, et al. IL4 (interleukin 4) induces autophagy in B cells leading to exacerbated asthma. Autophagy. 2018;14(3):450-464.